Europe Cancer Screening Market (2018-2023)

Publisher Name :
Date: 19-Sep-2018
No. of pages: 90

Europe cancer screening market

Europe after North America is the second largest market leading the cancer screening market. The market is forecasted t- grow at a compound annual growth rate of (CAGR) of 8.1% resulting in an annual revenue of USD 22.43 Bn during the forecast period (2018-2023). Increase in the aging population along with the rise in the number of cancer incidences is a key driving factor for the market. Western Europe is moving fast towards the adoption of performance-based remuneration systems.

By end users, the market is segmented int- hospitals, laboratories and independent physicians and clinics. The Laboratory segment will witness a progressive growth during the forecast period 2018-2023 while the hospital segment will account for the maximum revenue of USD 11.18 billion during the forecast period.

By screening type, the market is segmented int- laboratory, genetic, imaging, biopsy and endoscopy tests. Genetic, biopsy and endoscopy will be the leading segments during the forecast period 2018-2023.

By application type, the market can be segmented int- lung, breast, melanoma, kidney and colorectal cancer types. Colorectal, kidney, melanoma and breast cancer will occupy a larger share of the market during the forecast period 2018-2023.

By countries, the market is divided int- the United Kingdom (U.K.), France and Germany.

Key growth factors

Rise in the aging population, changing environmental conditions along with the adoption of a sedentary lifestyle is contributing t- more cancer-related cases.

Threats and key players

Stringent regulations along with regulatory inter and intra state barriers pose many challenges for the region. Lack of associated funding and transparency in medical procedures turn out t- be as threats t- the market.

Key players in the European cancer screening market are F. Hoffman-La- Roche Ltd, Bayer AG, and Johnson & Johnson, Pfizer, Merck & co.

What is covered in the report?

1. Overview of the European cancer screening market.

2. Market drivers and challenges in the European cancer screening market.

3. Market trends in the European cancer screening market.

4. Historical, current and forecasted market size data for Europe market segmentation based on type of end users (hospitals, laboratories, independent physicians and clinics) - by type of screening (laboratory, genetic, imaging, biopsy and endoscopy) -by application (lung, breast, melanoma, kidney and colorectal).

5. Historical, current and forecasted market size data for Europe market segmentation based on end-users (hospitals, laboratories, independent physicians and clinics) - by type of screening type(laboratory, genetic, imaging, biopsy and endoscopy) -by application (lung, breast, melanoma, kidney and colorectal).

6. Historical, current and forecasted market size data of the cancer screening market by countries UK, Germany and Others (Other parts of Europe) - by revenue .

7. Historical, current and forecasted market size data for country-wise segments - by revenue.

8. Analysis of the competitive landscape and profiles of major competitors operating in the European market.

Why buy?

- Understand the demand for the cancer screening market t- determine the viability of the market.

- Understand the country-specific market size and observations for each segment.

- Develop strategies based on the drivers, trends and highlights for each of the segments.

- Evaluate the value chain t- determine the workflow and t- get an idea of the current position where you are placed.

- Recognize the key competitors of this market and respond accordingly.

- Identify the initiatives and growth strategies taken by the major companies and decide the direction of further growth.

- Define the competitive positioning by comparing the products and services compared with the key players in the market.

Customizations available

With the given market data, Netscribes offers customizations according t- specific needs. Write t- us at [email protected].

Europe Cancer Screening Market (2018-2023)

Table of Contents

Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary

Chapter 2: Europe cancer screening market - market overview
2.1. Europe market overview - market trends, market attractiveness analysis, country-wise market revenue (USD)
2.2. Europe - market drivers and challenges
2.3. Value chain analysis - cancer screening market
2.4. Porter's five forces analysis
2.5. Market segmentation based on type of end users (hospitals, laboratory, independent physicians and clinics)
2.5. a. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. b. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. c. Independent physicians and clinics revenue - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. d. Growth drivers and key challenges
2.6. Market segmentation based on type of screening (Laboratory, genetic, imaging, biopsy and endoscopy) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
2.6. a. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. b. Genetic - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. c. Imaging - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. d. Biopsy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. e. Endoscopy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. f. Growth drivers and key challenges
2.7. Market segmentation based on type of application (lung, breast, melanoma, kidney and colorectal) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
2.7. a. Lung - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. b. Breast - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. c. Melanoma - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. d. Kidney - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. e. Colorectal - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. f. Growth drivers and key challenges
2.8. Major country penetration

Chapter 3. The UK cancer screening market
3.1. The UK market overview - market trends, market attractiveness analysis, country-wise market revenue (USD)
3.2. Market segmentation based on type of end users (hospitals, laboratory, independent physicians and clinics)
3.2. a. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2. b. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2. c. Independent physicians and clinics revenue - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2. d. Growth drivers and key challenges
3.3. Market segmentation based on type of screening (laboratory, genetic, imaging, biopsy and endoscopy) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
3.3. a. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. b. Genetic - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. c. Imaging - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. d. Biopsy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. e. Endoscopy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. f. Growth drivers and key challenges
3.4. Market segmentation based on type of application (lung, breast, melanoma, kidney and colorectal) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
3.4. a. Lung - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. b. Breast - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. c. Melanoma - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. d. Kidney - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. e. Colorectal - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. f. Growth drivers and key challenges

Chapter 4. Germany cancer screening market
4.1. Germany market overview - market trends, market attractiveness analysis, country-wise market revenue (USD)
4.2. Market segmentation based on type of end users (hospitals, laboratory, independent physicians and clinics)
4.2. a. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.2. b. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.2. c. Independent physicians and clinics revenue - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.2. d. Growth drivers and key challenges
4.3. Market segmentation based on type of screening (laboratory, genetic, imaging, biopsy and endoscopy) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
4.3. a. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. b. Genetic - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. c. Imaging - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. d. Biopsy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. e. Endoscopy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. f. Growth drivers and key challenges
4.4. Market segmentation based on type of application (lung, breast, melanoma, kidney and colorectal) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
4.4. a. Lung - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. b. Breast - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. c. Melanoma - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. d. Kidney - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. e. Colorectal - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. f. Growth drivers and key challenges

Chapter 5. Others (the rest of Europe) cancer screening market
5.1. Others (the rest of Europe) market overview - market trends, market attractiveness analysis, country-wise market revenue (USD)
5.2. Market segmentation based on type of end users (hospitals, laboratory, independent physicians and clinics)
5.2. a. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.2. b. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.2. c. Independent physicians and clinics revenue - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.2. d. Growth drivers and key challenges
5.3. Market segmentation based on the type of screening type (laboratory, genetic, imaging, biopsy and endoscopy) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
5.3. a. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. b. Genetic - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. c. Imaging - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. d. Biopsy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. e. Endoscopy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. f. Growth drivers and key challenges
5.4. Market segmentation based on type of application (lung, breast, melanoma, kidney and colorectal) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
5.4. a. Lung - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. b. Breast - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. c. Melanoma - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. d. Kidney - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. e. Colorectal - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. f. Growth drivers and key challenges

Chapter 6: Competitive landscape
6.1. F. Hoffman La Roche Ltd
6.1. a. Company snapshot
6.1. b. Product offerings
6.1. c. Growth strategies
6.1. d. Initiatives
6.1. e. Geographical presence
6.1. f. Key numbers
6.2. Bayer AG
6.2. a. Company snapshot
6.2. b. Product offerings
6.2. c. Growth strategies
6.2. d. Initiatives
6.2. e. Geographical presence
6.2. f. Key numbers
6.3. Johnson & Johnson
6.3. a. Company snapshot
6.3. b. Product offerings
6.3. c. Growth strategies
6.3. d. Initiatives
6.3. e. Geographical presence
6.3. f. Key numbers
6.4. Pfizer
6.4. a. Company snapshot
6.4. b. Product offerings
6.4. c. Growth strategies
6.4. d. Initiatives
6.4. e. Geographical presence
6.4. f. Key numbers
6.5. Merck & Co.
6.5. a. Company snapshot
6.5. b. Product offerings
6.5. c. Growth strategies
6.5. d. Initiatives
6.5. e. Geographical presence
6.5. f. Key numbers

Chapter 7: Conclusion

Chapter 8: Appendix
8.1. List of tables
8.2. Assumptions
8.3. Research and methodology
8.4. About Netscribes Inc.
Note: The Table of Contents (Toc) provided above contains the targeted coverage. The coverage is subject to change as we progress with the research.
Disclaimer: The report will be delivered within 5-7 business days post payment confirmation
  • Global Prostate Cancer Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Prostate Cancer Diagnostics market size was valued at US$ 13140 million in 2023. With growing demand in downstream market, the Prostate Cancer Diagnostics is forecast to a readjusted size of US$ 22650 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global Prostate Cancer Diagnostics market. Prostate Cancer Diagnostics are expected to show stable growth in th......
  • Global Checkpoint Inhibitors for Treating Cancer Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 83
    According to our LPI (LP Information) latest study, the global Checkpoint Inhibitors for Treating Cancer market size was valued at US$ 12220 million in 2023. With growing demand in downstream market, the Checkpoint Inhibitors for Treating Cancer is forecast to a readjusted size of US$ 63530 million by 2030 with a CAGR of 26.6% during review period. The research report highlights the growth potential of the global Checkpoint Inhibitors for Treating Cancer market. Checkpoint Inhibitors for......
  • Global PSA Test Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111
    According to our LPI (LP Information) latest study, the global PSA Test market size was valued at US$ 499.9 million in 2023. With growing demand in downstream market, the PSA Test is forecast to a readjusted size of US$ 861.8 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global PSA Test market. PSA Test are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global HPV Testing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87
    According to our LPI (LP Information) latest study, the global HPV Testing market size was valued at US$ 784.6 million in 2023. With growing demand in downstream market, the HPV Testing is forecast to a readjusted size of US$ 1398.7 million by 2030 with a CAGR of 8.6% during review period. The research report highlights the growth potential of the global HPV Testing market. HPV Testing are expected to show stable growth in the future market. However, product differentiation, reducing cos......
  • Global Prostate Cancer Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 102
    According to our (Global Info Research) latest study, the global Prostate Cancer Diagnostics market size was valued at USD 13820 million in 2023 and is forecast to a readjusted size of USD 22870 million by 2030 with a CAGR of 7.5% during review period. The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be ......
  • Global Pap Tests and HPV Tests Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 130
    The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......
  • Global Pap Tests and HPV Tests Professional Survey Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 106
    The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......
  • Global Checkpoint Inhibitors For Treating Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Checkpoint Inhibitors For Treating Cancer market: According to our latest research, the global Checkpoint Inhibitors For Treating Cancer market looks promising in the next 5 years. As of 2022, the global Checkpoint Inhibitors For Treating Cancer market was estimated at USD 18595.4 million, and it's anticipated to reach USD 42557.61 million in 2028, with a CAGR of 14.8% during the forecast years. Checkpoint inhibitor is a type of drug used in immunoth......
  • Global Solid Tumor Testing Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 100
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs